CAY10505 in (ML246) 34)35/h2-3

34)35/h2-3

Administration of GKT137831 throughout the 72-hour period of normoxia or hypoxia exposure attenuates HPASMC proliferation under normoxic conditions at the 20 μM concentration but had no effect on proliferation in normoxic HPAECs

Talukdar S

Treatment of diet-induced obese mice with SR9009 decreased obesity by reducing fat mass and markedly improved dyslipidaemia and hyperglycaemia

CAY10505 in (ML246) 34)35/h2-3CAY10505 is a phosphatidylinositol 3 kinase inhibitor , was found to significantly improve acetylcholine induced endothelium dependent relaxation, serum nitrate and (or) nitrite level, glutathione level, and the vascular endothelial lining in hypertensive rats. CAY10505 , may improve hypertension associated vascular endothelial dysfunction. Inhibition of PI3K might be a useful approach in the therapeutics of vascular endothelium dysfunction. Product